Does the size of response to cabozantinib plus nivolumab affect clinical outcomes?
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
Previously, researchers found some genes that helped identify which patients [...]
The International Kidney Cancer Symposium (IKCS) 2021 took place in [...]
The Scottish Medicines Consortium (SMC) has approved the use of [...]
Combinations of immunotherapy and vascular endothelial growth factor (VEGF) inhibitors [...]
The cabozantinib/nivolumab combination has been shown to be effective at [...]
Despite the advances in first-line treatments for metastatic renal cell [...]
The increase in the number of first-line treatments for metastatic [...]
The use of combination therapies for the first-line treatment of [...]
There is very little information on the effectiveness of sunitinib [...]